You are here

Oncology Molecular Diagnostics Market Research Report, Upcoming Trends, Demand, Regional Analysis and Forecast 2025

According to IMARC Group’s latest report, titled “Oncology Molecular Diagnostics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025,” the global oncology molecular diagnostics market to exhibit strong growth during the next five years.

Oncology molecular diagnostics are used to detect the presence of cancerous cells by analyzing the biological molecules. Various tests are performed on blood, saliva, and tumor tissue samples to identify and measure specific genetic sequences in DNA, RNA, and cell proteins. Oncology molecular diagnostics assist in early cancer detection and provide required information pertaining to personalized cancer treatment. They are often used in clinical and point-of-care (POC) testing, along with identifying pathogens and infectious diseases present in the donated blood samples in blood banks.

Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/oncology-molecular-diagnostics-market/request...

Market Trends

The increasing occurrence of oncological disorders due to unhealthy consumer lifestyles, rising geriatric population, and the growing tobacco consumption, is primarily driving the demand for oncology molecular diagnostics. In line with this, the growing need for early and accurate diagnosis, coupled with several advancements in next-generation sequencing (NGS) techniques, further contributes to the market growth. Moreover, the rising prevalence of viral and bacterial infections, along with the expanding number of blood donation campaigns, is further bolstering the demand for oncology molecular diagnostics.

The report has segmented the market on the basis of cancer type, product, technology, end-user and region.

Breakup by Cancer Type:

Breast Cancer
Prostate Cancer
Colorectal Cancer
Cervical Cancer
Liver Cancer
Lung Cancer
Blood Cancer
Others

Breakup by Product:

Instruments
Reagents
Others

Breakup by Technology:

Polymerase Chain Reaction (PCR)
In Situ Hybridization
Chips and Microarrays
Isothermal Nucleic Acid Amplification Technology (INAAT)
Mass Spectrometry
DNA and NGS Sequencing
Transcription Mediated Amplification (TMA)
Others

Breakup by End-User:

Hospitals and Clinics
Reference Laboratories
Others

For more information about this report:
https://www.imarcgroup.com/oncology-molecular-diagnostics-market

Breakup by Region:

North America
Asia Pacific:
Europe
Latin America
Middle East and Africa

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., Abbott Laboratories, Bayer AG, BD (Becton, Dickinson and Company), Cepheid Inc. (Danaher Corporation), F. Hoffmann-La Roche AG, Hologic Inc., Qiagen N.V., Siemens Healthcare and Sysmex Corporation.

Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
USA: +1-631-791-1145
Follow us on twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group